ABSTRACT
Improved biomarkers are of vital importance for cancer detection, diagnosis and prognosis. While significant advances in understanding the molecular basis of disease are underway in genomics, proteomics will ultimately delineate the functional units of a cell: proteins and their intricate interactive networks and signalling pathways in health and disease.
